Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo

Press/Media

Period	9 Nov 2022

Media coverage

Title	Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Media name/outlet	Endpts.com
Country/Territory	United States
Date	9/11/22
URL	ct.moreover.com/?a=49208673611&p=1gw&v=1&x=kvSTKu_OQ3NBc2IzgK0JIw
Persons	Israel Lowy,